Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Silver RT, Woolf SH, Hehlmann R, et al. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for American Society of Hematology. Blood. 1999;94(1):1517–36.
2. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med. 1986;104(2):155–63. https://doi.org/10.7326/0003-4819-104-2-155 .
3. Talpaz M, McCredie KB, Mavligit GM, Gutterman JU. Leukocyte interferon induced myeloid cytoreduction in chronic myelogenous leukemia. Blood. 1983;62(3):689–92.
4. Kantarjian HM, O’Brien S, Cortes JE, et al. Complete cytogenetic and molecular responses to interferon alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis. Cancer. 2003;97(4):1033–41. https://doi.org/10.1002/cncr.11223 .
5. Mahon FX, Debbrel X, Cony-Makhoul P, et al. Follow up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa. J Clin Oncol. 2002;20(1):214–20. https://doi.org/10.1200/JCO.2002.20.1.214 .
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献